Biodesign

Korean Society for Structural Biology (한국구조생물학회)
권호 표지

Specific Binding and Catalytic Activation of the MAPK-MKP Complex

  • Kim, Myeongbin (Department of Bioengineering, College of Engineering, Hanyang University) ;
  • Ryu, Seong Eon (Department of Bioengineering, College of Engineering, Hanyang University)
  • Received : 2018.11.20
  • Accepted : 2018.12.05
  • Published : 2018.12.31

⟨ Previous Next ⟩

Abstract

Mitogen-activated protein kinases (MAPKs) are one of the most important enzymes in various cellular activities, and the MAPK signaling pathway is implicated in many disorders. MAPK phosphatases (MKPs) are regulators that contain a MAPK-binding domain (MBD) for MAPK recognition, and a catalytic domain (CD), for dephosphorylation and inactivation of MAPKs. Due to their crucial role in regulating the MAPK pathway, MKPs are regarded as a potential drug target in various diseases. Attempts have also been made to regulate the MAPK pathway by reducing the MKP activity. For drug development, it is important to understand the key features of MAPK-MKP complex formation. This review summarizes the studies on MAPK-MKP complexes, mainly focusing on their selective recognition and catalytic activation.

Keywords

References

  1. Camps, M., Nichols, A., Gillieron, C., Antonsson, B., Muda, M., Chabert, C., Boschert, U., and Arkinstall, S. (1998). Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262-1265. https://doi.org/10.1126/science.280.5367.1262
  2. Chen, P., Hutter, D., Yang, X., Gorospe, M., Davis, R.J., and Liu, Y. (2001). Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MKP-2 and their ability to catalytically activate the phosphatase. J Biol Chem 276, 29440-29449. https://doi.org/10.1074/jbc.M103463200
  3. Dechert, U., Adam, M., Harder, K.W., Clark-Lewis, I., and Jirik, F. (1994). Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains. J Biol Chem 269, 5602-5611.
  4. Farooq, A., Chaturvedi, G., Mujtaba, S., Plotnikova, O., Zeng, L., Dhalluin, C., Ashton, R., and Zhou, M.M. (2001). Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2. Mol Cell 7, 387-399. https://doi.org/10.1016/S1097-2765(01)00186-1
  5. Farooq, A., and Zhou, M.M. (2004). Structure and regulation of MAPK phosphatases. Cell Signal 16, 769-779. https://doi.org/10.1016/j.cellsig.2003.12.008
  6. Fjeld, C.C., Rice, A.E., Kim, Y., Gee, K.R., and Denu, J.M. (2000). Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase. J Biol Chem 275, 6749-6757. https://doi.org/10.1074/jbc.275.10.6749
  7. Haneda, M., Sugimoto, T., and Kikkawa, R. (1999). Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. Eur J Pharmacol 365, 1-7. https://doi.org/10.1016/S0014-2999(98)00857-7
  8. He, R.J., Yu, Z.H., Zhang, R.Y., and Zhang, Z.Y. (2014). Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin 35, 1227-1246. https://doi.org/10.1038/aps.2014.80
  9. Hutter, D., Chen, P., Barnes, J., and Liu, Y. (2000). Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem J 352, 155-163. https://doi.org/10.1042/bj3520155
  10. Jeong, D.G., Cho, Y.H., Yoon, T.S., Kim, J.H., Ryu, S.E., and Kim, S.J. (2007). Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase. Proteins: Structure, Function, and Bioinformatics 66, 253-258.
  11. Jeong, D.G., Yoon, T.S., Kim, J.H., Shim, M.Y., Jung, S.K., Son, J.H., Ryu, S.E., and Kim, S.J. (2006). Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: structural insight into constitutively active phosphatase. J Mol Biol 360, 946-955. https://doi.org/10.1016/j.jmb.2006.05.059
  12. Johnson, G.L., and Lapadat, R. (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912. https://doi.org/10.1126/science.1072682
  13. Kondoh, K., and Nishida, E. (2007). Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 1773, 1227-1237. https://doi.org/10.1016/j.bbamcr.2006.12.002
  14. Kumar, G.S., Zettl, H., Page, R., and Peti, W. (2013). Structural Basis for the Regulation of the MAP Kinase p38${\alpha}$ by the Dual Specificity Phosphatase 16 MAP Kinase Binding Domain in Solution. J Biol Chem 288, 28347-28356. https://doi.org/10.1074/jbc.M113.499178
  15. Lin, Y.-W., and Yang, J.-L. (2006). Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J Biol Chem 281, 915-926. https://doi.org/10.1074/jbc.M508720200
  16. Liu, S., Sun, J.P., Zhou, B., and Zhang, Z.Y. (2006). Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc Natl Acad Sci U S A 103, 5326-5331. https://doi.org/10.1073/pnas.0510506103
  17. Liu, X., Zhang, C.S., Lu, C., Lin, S.C., Wu, J.W., and Wang, Z.X. (2016). A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation. Nat Commun 7, 10879. https://doi.org/10.1038/ncomms10879
  18. Lu, C., Liu, X., Zhang, C.S., Gong, H., Wu, J.W., and Wang, Z.X. (2017). Structural and dynamic insights into the mechanism of allosteric signal transmission in ERK2-mediated MKP3 activation. Biochemistry 56, 6165-6175. https://doi.org/10.1021/acs.biochem.7b00827
  19. Mark, J.K., Aubin, R.A., Smith, S., and Hefford, M.A. (2008). Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding. J Biol Chem 283, 28574-28583. https://doi.org/10.1074/jbc.M801747200
  20. Molina, G., Vogt, A., Bakan, A., Dai, W., De Oliveira, P.Q., Znosko, W., Smithgall, T.E., Bahar, I., Lazo, J.S., and Day, B.W. (2009). Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nat Chem Biol 5, 680-687. https://doi.org/10.1038/nchembio.190
  21. Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A., and Arkinstall, S. (1996). The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271, 27205-27208. https://doi.org/10.1074/jbc.271.44.27205
  22. Seternes, O. M., Kidger, A.M., and Keyse, S.M. (2019). Dual-specificity MAP kinase phosphatases in health and disease. Biochim Biophys Acta Mol Cell Res 1866, 124-143. https://doi.org/10.1016/j.bbamcr.2018.09.002
  23. Slack, D.N., Seternes, O.M., Gabrielson, M., and Keyse, S.M. (2001). Distinct binding determinants for ERK2/p38a and JNK MAP kinases mediate catalytic activation and substrate selectivity of MAP kinase phosphatase-1. J Biol Chem 276, 16491-164500. https://doi.org/10.1074/jbc.M010966200
  24. Stewart, A.E., Dowd, S., Keyse, S.M., and McDonald, N.Q. (1999). Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nat Struct Biol 6, 174-181. https://doi.org/10.1038/5861
  25. Tanoue, T., Moriguchi, T., and Nishida, E. (1999). Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem 274, 19949-19956. https://doi.org/10.1074/jbc.274.28.19949
  26. Tanoue, T., Yamamoto, T., Maeda, R., and Nishida, E. (2001). A novel MAPK phosphatase, MKP-7 acts preferentially on JNK/SAPK and p38alpha and beta MAPKs. J Biol Chem 276, 26629-26639. https://doi.org/10.1074/jbc.M101981200
  27. Widmann, C., Gibson, S., Jarpe, M.B., and Johnson, G.L. (1999). Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79, 143-180. https://doi.org/10.1152/physrev.1999.79.1.143
  28. Zhang, Y.Y., Wu, J.W., and Wang, Z.X. (2011a). A distinct interaction mode revealed by the crystal structure of the kinase p38${\alpha}$ with the MAPK binding domain of the phosphatase MKP5. Sci Signal 4, ra88.
  29. Zhang, Y.Y., Wu, J.W., and Wang, Z.-X. (2011b). MAP kinase phosphatase 3-mediated crosstalk between MAP kinases ERK2 and p38${\alpha}$. J Biol Chem 286, 16150-16162. https://doi.org/10.1074/jbc.M110.203786
  30. Zhang, Y., Blattman, J.N., Kennedy, N.J., Duong, J., Nguyen, T., Wang, Y., Davis, R.J., Greenberg, P.D., Flavell, R.A., and Dong, C. (2004). Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430, 793-797. https://doi.org/10.1038/nature02764
  31. Zhou, B., Wu, L., Shen, K., Zhang, J., Lawrence, D.S., and Zhang, Z.Y. (2001). Multiple regions of MAP kinase phosphatase 3 are involved in its recognition and activation by ERK2. J Biol Chem 276, 6506-6515. https://doi.org/10.1074/jbc.M009753200
  32. Zhou, B., Zhang, J., Liu, S., Reddy, S., Wang, F., and Zhang, Z.Y. (2006). Mapping ERK2-MKP3 binding interfaces by hydrogen/deuterium exchange mass spectrometry. J Biol Chem 281, 38834-38844. https://doi.org/10.1074/jbc.M608916200